Latest Leadership Changes News

Macquarie Group reported a decline in net profit contribution for the first quarter of FY26, driven by mixed performances across its divisions, while maintaining a robust capital surplus and announcing a key CFO transition.

Kuniko Limited has applied for NOK 60 million in funding to develop a sustainable, low-emission battery metals supply chain in Norway, partnering with industry and research leaders including Stellantis.

Bapcor reports a softer FY25 with pro-forma NPAT of $81-82 million and statutory NPAT sharply lower at $31-34 million, citing operational disruptions and a challenging retail environment. The company also announces key board resignations amid a strategic reset.

Fortescue Metals Group delivered record iron ore shipments in FY25 alongside a rare cost decline, while recalibrating its green energy ambitions and maintaining a strong financial position.

Mount Gibson Iron Limited reports steady FY25 iron ore sales amid operational challenges and announces a strategic entry into gold with a 50% stake in the Central Tanami Project.

Yowie Group Limited has explained the delayed filing of director interest notices following a contested board change, committing to stronger governance measures to prevent future lapses.

Raptis Group Limited has confirmed that director James Raptis will resign effective 30 September 2025, affirming the company’s compliance with ASX continuous disclosure rules.

Karoon Energy announces CEO Dr Julian Fowles will depart by mid-2026 as the company relocates key corporate roles to Brazil and the USA, initiating a global search for a Houston-based successor.

Astute Metals NL sharpens its focus on Nevada’s rich mineral landscape, unveiling fresh high-grade gold targets at Needles and reaffirming lithium potential at Red Mountain amid leadership changes.

Aerometrex has completed a strategic review that delivers $2 million in cost savings and initiates data monetisation, positioning the company for accelerated growth in FY26.

Highfield Resources has entered a significant non-binding agreement with China’s Qinghai Salt Lake Industry for a US$300 million equity injection, aiming to fast-track its Muga potash mine development and expand its global footprint.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart technology, reporting promising clinical results in Crohn’s disease and GVHD, alongside a $3.5 million capital raise to fuel next-stage development.